SSA
Schonfeld Strategic Advisors Portfolio holdings
AUM
$13.3B
1-Year Return
26.83%
This Quarter Return
+14.78%
1 Year Return
+26.83%
3 Year Return
+97.05%
5 Year Return
+189.63%
10 Year Return
–
AUM
$13.3B
AUM Growth
-$1.61B
(-11%)
Cap. Flow
-$2.99B
Cap. Flow
% of AUM
-22.56%
Top 10 Holdings %
Top 10 Hldgs %
19.71%
Holding
2,547
New
501
Increased
701
Reduced
653
Closed
660
Top Buys
| 1 |
Caterpillar
CAT
|
+$110M |
| 2 |
NVIDIA
NVDA
|
+$94.7M |
| 3 |
ARK 21Shares Bitcoin ETF
ARKB
|
+$92.2M |
| 4 |
CSX Corp
CSX
|
+$83M |
| 5 |
TSMC
TSM
|
+$73.1M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.42B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$523M |
| 3 |
Meta Platforms (Facebook)
META
|
+$197M |
| 4 |
Vertiv
VRT
|
+$114M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$102M |
Sector Composition
| 1 | Technology | 16.68% |
| 2 | Industrials | 15.95% |
| 3 | Financials | 10.39% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Healthcare | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
CVS Health
CVS
$91B
| $10M | 0.07% |
145,458
+1,416
| +1% | +$97.7K |
|
302
Vale
VALE
$44.2B
| $10M | 0.07% |
1,032,180
+183,631
| +22% | +$1.78M |
|
303
Target
TGT
$41.3B
| $9.89M | 0.07% |
100,239
+86,261
| +617% | +$8.51M |
|
304
Macerich
MAC
$4.57B
| $9.77M | 0.07% |
603,934
-664,627
| -52% | -$10.8M |
|
305
Abbott
ABT
$230B
| $9.76M | 0.07% |
71,744
+55,026
| +329% | +$7.48M |
|
306
Jabil
JBL
$22.5B
| $9.73M | 0.07% |
44,626
+25,979
| +139% | +$5.67M |
|
307
Mr. Cooper
COOP
$13.8B
| $9.71M | 0.07% |
65,091
+58,205
| +845% | +$8.68M |
|
308
Garmin
GRMN
$45.9B
| $9.68M | 0.07% |
46,360
+30,039
| +184% | +$6.27M |
|
309
McDonald's
MCD
$223B
| $9.67M | 0.07% |
33,106
-59,554
| -64% | -$17.4M |
|
310
Charles River Laboratories
CRL
$7.75B
| $9.65M | 0.07% |
63,587
+61,677
| +3,229% | +$9.36M |
|
311
Dick's Sporting Goods
DKS
$17.6B
| $9.62M | 0.07% |
48,623
-56,431
| -54% | -$11.2M |
|
312
Thomson Reuters
TRI
$79.2B
| $9.62M | 0.07% |
47,808
-32,273
| -40% | -$6.49M |
|
313
Albemarle
ALB
$8.54B
| $9.6M | 0.07% |
153,153
-2,981
| -2% | -$187K |
|
314
Edwards Lifesciences
EW
$46.9B
| $9.58M | 0.07% |
122,507
-338,741
| -73% | -$26.5M |
|
315
Entergy
ETR
$38.8B
| $9.58M | 0.07% |
115,268
+63,923
| +124% | +$5.31M |
|
316
KKR & Co
KKR
$122B
| $9.58M | 0.07% |
72,002
-166,552
| -70% | -$22.2M |
|
317
Couchbase
BASE
$1.35B
| $9.56M | 0.07% |
+392,255
| New | +$9.56M |
|
318
Willis Towers Watson
WTW
$32.1B
| $9.56M | 0.06% |
31,176
+5,104
| +20% | +$1.56M |
|
319
Stride
LRN
$7.25B
| $9.52M | 0.06% |
65,590
+10,766
| +20% | +$1.56M |
|
320
Clorox
CLX
$15.4B
| $9.44M | 0.06% |
78,635
+60,071
| +324% | +$7.21M |
|
321
DaVita
DVA
$9.77B
| $9.4M | 0.06% |
+66,008
| New | +$9.4M |
|
322
Pinnacle West Capital
PNW
$10.4B
| $9.25M | 0.06% |
103,348
+24,591
| +31% | +$2.2M |
|
323
Zeekr
ZK
$7.61B
| $9.24M | 0.06% |
+362,257
| New | +$9.24M |
|
324
Neurocrine Biosciences
NBIX
$14.3B
| $9.17M | 0.06% |
72,945
+65,782
| +918% | +$8.27M |
|
325
Lamb Weston
LW
$7.96B
| $9.15M | 0.06% |
176,384
-136,425
| -44% | -$7.07M |
|